Gene · 7980
Papers2,421
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 2,421
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Single-Cell Transcriptomic Census of Endothelial Changes Induced by Matrix Stiffness and the Association with Atherosclerosis. | Adv Funct Mater | 2022 | 36816792 | PubTator, text mining | PubMed |
| Isolated growth hormone deficiency in children with vertically transmitted short stature: What do the genes tell us? | Front Endocrinol (Lausanne) | 2022 | 36714562 | PubTator, text mining | PubMed |
| Using publicly available datasets to identify population-based transcriptomic landscape contributing to the aggressiveness of breast cancer in young women. | Front Genet | 2022 | 36685821 | PubTator, text mining | PubMed |
| Non-Syndromic Hearing Loss in a Romanian Population: Carrier Status and Frequent Variants in the GJB2 Gene. | Genes (Basel) | 2022 | 36672810 | PubTator, text mining | PubMed |
| Co-expression of fibrotic genes in inflammatory bowel disease; A localized event? | Front Immunol | 2022 | 36632136 | PubTator, text mining | PubMed |
| Homozygous GRHPR C.494G>A mutation is deleterious that causes early onset of nephrolithiasis in West Bengal, India. | Front Mol Biosci | 2022 | 36619171 | PubTator, text mining | PubMed |
| Krüppel-like Factor 6 Suppresses the Progression of Pancreatic Cancer by Upregulating Activating Transcription Factor 3. | J Clin Med | 2022 | 36615000 | PubTator, text mining | PubMed |
| Research Progress on the Predicting Factors and Coping Strategies for Postoperative Recurrence of Esophageal Cancer. | Cells | 2022 | 36611908 | PubTator, text mining | PubMed |
| Severe early-onset manifestations of generalized arterial calcification of infancy (mimicking severe coarctation of the aorta) with ABCC6 gene variant - Case report and literature review. | Front Cardiovasc Med | 2022 | 36606277 | PubTator, text mining | PubMed |
| Cellular senescence in cancer: clinical detection and prognostic implications. | J Exp Clin Cancer Res | 2022 | 36575462 | PubTator, text mining | PubMed |
| Novel and Founder Pathogenic Variants in X-Linked Alport Syndrome Families in Greece. | Genes (Basel) | 2022 | 36553470 | PubTator, text mining | PubMed |
| Dose Dependence Effect in Biallelic WNT10A Variant-Associated Tooth Agenesis Phenotype. | Diagnostics (Basel) | 2022 | 36553094 | PubTator, text mining | PubMed |
| Single-cell transcriptomic, transcriptomic, and metabolomic characterization of human atherosclerosis. | Ann Transl Med | 2022 | 36544681 | PubTator, text mining | PubMed |
| Porosity of Molecularly Imprinted Polymers Investigated by 129Xe NMR Spectroscopy. | ACS Appl Polym Mater | 2022 | 36532888 | PubTator, text mining | PubMed |
| Identification and verification of a novel epigenetic-related gene signature for predicting the prognosis of hepatocellular carcinoma. | Front Genet | 2022 | 36531219 | PubTator, text mining | PubMed |
| Geno- and phenotypic characteristics and clinical outcomes of CACNA1C gene mutation associated Timothy syndrome, "cardiac only" Timothy syndrome and isolated long QT syndrome 8: A systematic review. | Front Cardiovasc Med | 2022 | 36523353 | PubTator, text mining | PubMed |
| A vasculogenic mimicry prognostic signature associated with immune signature in human gastric cancer. | Front Immunol | 2022 | 36505458 | PubTator, text mining | PubMed |
| Forward Genetic Screens as Tools to Investigate Role and Mechanisms of EMT in Cancer. | Cancers (Basel) | 2022 | 36497409 | PubTator, text mining | PubMed |
| Epigenetics in Pancreatic Ductal Adenocarcinoma: Impact on Biology and Utilization in Diagnostics and Treatment. | Cancers (Basel) | 2022 | 36497404 | PubTator, text mining | PubMed |
| A novel stop-gain pathogenic variant in FLT4 and a nonsynonymous pathogenic variant in PTPN11 associated with congenital heart defects. | Eur J Med Res | 2022 | 36496429 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7980/papers?page=17